Prevalence and Psychiatric Comorbidity of Attention-Deficit/Hyperactivity Disorder in an Adolescent Finnish Population SUSAN L. SMALLEY, Ph.D., JAMES J. McGOUGH, M.D., IRMA K. MOILANEN, M.D., Ph.D., SANDRA K. LOO, Ph.D., ANJA TAANILA, Ph.D., HANNA EBELING, M.D., Ph.D., TUULA HURTIG, Ph.D., MARIKA KAAKINEN, M.Sc., LORIE A. HUMPHREY, Ph.D., JAMES T. McCRACKEN, M.D., TEPPO VARILO, M.D., Ph.D., MAY H. YANG, M.A., STANLEY F. NELSON, M.D., LEENA PELTONEN, M.D., MARJO-RIITTA JÄRVELIN, M.D., Ph.D. Journal of the American Academy of Child & Adolescent Psychiatry Volume 46, Issue 12, Pages 1575-1583 (December 2007) DOI: 10.1097/chi.0b013e3181573137 Copyright © 2007 The American Academy of Child and Adolescent Psychiatry Terms and Conditions
Fig. 1 Chart of subject flow and diagnostic classification. Subject flow from SWAN scores to best estimate attention-deficit/hyperactivity disorder (ADHD) classification at various stages. Superscripts in each box refer to SWAN classification (A, B) or best estimate ADHD classification (C-F). SWAN = Strengths and Weaknesses of ADHD-Symptoms and Normal-Behavior Scale. Journal of the American Academy of Child & Adolescent Psychiatry 2007 46, 1575-1583DOI: (10.1097/chi.0b013e3181573137) Copyright © 2007 The American Academy of Child and Adolescent Psychiatry Terms and Conditions
Fig. 2 Strengths and Weaknesses of ADHD-Symptoms and Normal-Behavior Scale distributions in the Northern Finland Behavior Cohort. Graphs depict distributions for each subscale by sex. Arrows on the x-axis indicate 95% percentile cutoffs used to define caseness with values of .625, 0.125, and 0.278 for Inattentive, Hyperactive, and Combined, respectively. Obs = observations. Journal of the American Academy of Child & Adolescent Psychiatry 2007 46, 1575-1583DOI: (10.1097/chi.0b013e3181573137) Copyright © 2007 The American Academy of Child and Adolescent Psychiatry Terms and Conditions